Gut mRNA tech supercharges vaccine and GLP-1 delivery
From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go. But researchers still face a fundamental challenge: getting those therapies to the organs where they are needed m
From vaccines to gene therapies, mRNA medicines often rely on tiny fat-based particles called lipid nanoparticles, or LNPs, to carry treatments where they need to go. But researchers still face a fundamental challenge: getting those therapies to the organs where they are needed m This story matters for Science & Discovery readers tracking insect. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. InsectNews curates and briefs the science & discovery stories that matter. Our editorial policy →